Exclusive insight from experts in the lyophilization industry
A brief overview from Q&A sessions with:
• Fabrice Schlegel - Senior Engineer at Amgen
• Mohamed AbouGhaly - Postdoctoral Researcher at Purdue University
• Timothy McCoy, Associate Director, Pharmaceutical Development Biologics at Sanofi
*****What do you see as the greatest challenge to overcome in the field at the moment?*****
Fabrice Schlegel: Lack of resources invested by biotech companies in the development of more innovative processes for lyophilization.
Mohamed AbouGhaly: The greatest challenge is in turning process from a trial and error approach to a more systematic and predictable approach.
Timothy McCoy: Scalability is always a challenge; especially with the freezing step. There are currently techniques out there to better control the ice nucleation process, and to allow better control of primary and secondary drying.
*****What technology has really caught your eye in the Lyophilization field in the past year?*****
Fabrice Schlegel: The move from in-vivo to in-silico experiments to reduce the experimental burden related to lyophilization process development.
Mohamed AbouGhaly: The continuous advances in wireless temperature probes that can monitor products in process.
Timothy McCoy: I am not sure if there have been many new technological innovations over the last year, that are completely new to the field. However, many technologies have been improved and expanded. I am interested in the mini lyophilizer systems such as microFD and LyoCapsule; PAT technologies such as LyoDEA.
Full transcripts are available on the Download Centre of lyophilization-usa.com
To hear presentations from Timothy, Mohamed, Fabrice and many other industry experts, reserve your ticket at http://www.lyophilization-usa.com/openpr
Twitter - @SMIpharm & #lyousa
LinkedIn - SMi Pharma
+44 (0)20 7827 6000
Lyophilization USA Conference| November 15 - 16, 2018 | New Jersey
About SMi Group: Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network.
1 Westminster Bridge Road
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Exclusive insight from experts in the lyophilization industry here
News-ID: 1098139 • Views: 233
More Releases from SMi Group
Six Key Presentations at SMi's Inaugural Robotics & Automation in Pharma Confere …
SMi Group reports: Six key presentations featured at the Robotics & Automation in Pharma Conference in London on 21-22 February 2022 SMi Group are delighted to announce the launch of the inaugural Robotics and Automation in Pharma conference, taking place on 21st and 22nd February 2022 in London, UK. The 2022 conference theme is on the latest developments in the field surrounding the integration of Robotics and Automation into the Pharmaceutical
SMi Launches it’s 6th Annual Conference and Exhibition: Future Armored Vehicle …
Armoured Vehicles Situational Awareness 2022 4th- 5th April 2022, London, United Kingdom http://www.armouredvehicles-sa.com/ Sponsors: Ni-Or Providing the Armoured Vehicle Crew with the Information to Operate in the Complex Modern Battlespace The SMi Group are pleased to present the next annual conference in the sell-out portfolio of Armoured Vehicle events: Future Armoured Vehicles Situational Awareness (FAVSA) 2022, taking place on the 4th - 5th April 2022 in London. Militaries around the world are continuing to evolve
SMi Launches its 9th Annual Pre-Filled Syringes East Coast Conference
After nearly two years of virtual meetings the industry looks set to meet face to face and have some really important discussions and you are invited to join them. SMi’s 9th Annual Conference Pre-Filled Syringes East Coast Main Conference: April 25 - 26, 2022 | Workshops: April 27, 2022 Sheraton Boston Hotel, Boston, MA, USA www.pfsamericas.com/openPR1 Sponsors are: SCHOTT, ZEON Exhibitors: Owen Mumford Pharmaceutical Services, PHC Corporation, POLYPLASTICS- TOPAS, Weiss-Aug Group Device innovations, connected delivery
Only 6 weeks to go until The Transdermal and Microneedle Delivery Conference
SMi Reports: Time is running out to Register for SM’s inaugural conference: Transdermal and Microneedle Delivery will take place on 24th - 25th January 2022 SMi Group is proud to present the inaugural Transdermal and Microneedle Drug Delivery Conference, taking place on the 24th to 25th January 2022, in London, UK. The Conference will explore real world applications of microneedles in drug delivery and strategies for device design while engaging in
More Releases for Lyophilization
Freeze Drying / Lyophilization Equipment Market Share and Forecast to 2024
New York, November 23, 2018: The freeze drying market includes different accessories and frill required for completing lyophilization of various substances in the pharmaceutical and biotech companies. Freeze drying is the evacuation of ice or other solidified solvents from a material through the procedure of sublimation and the expulsion of bound water atoms through the procedure of desorption. Lyophilization and freeze drying are terms that are utilized conversely relying
Achieving Controlled Nucleation During Aseptic Lyophilization
Controlled nucleation is essential for obtaining high-quality lyophilized products with intra- and inter-batch consistency. Two approaches to achieving controlled nucleation have been investigated recently: creating a pressure differential and using an ice fog to insert seed crystals into the vials within the lyophilization chamber. Morrisa Jones, Senior Scientist, Vaccine Drug Product Development Merck, who is speaking at the SMi’s Groups’ Lyophilization USA Conference she will be comparing and contrasting two
Optimization of Lyophilization and alternatives to conventional Freeze-Drying me …
SMi Group reports: Alina Alexeenko of Purdue University presenting LyoHub's overview and strategies for the future of lyophilization and alternatives to conventional methods Optimization of Lyophilization is the quest for the industry. The process of lyophilization is used to stabilize products susceptible to physical and chemical degradation, and is often time-consuming, expensive, and has an energy efficiency of less than 5 percent. The rise of biologics, which are heavily reliant on
Lyophilization USA Conference – official agenda published
SMi Group reports: exploring the future of lyophilization at the established event this November Building on knowledge and experience of the market, SMi Group is pleased to announce the release of the official agenda for the 4th annual Lyophilization USA Conference, which is due to take place in Iselin, New Jersey on November 15 - 16, 2018. Lyophilization is one of the most time-consuming and expensive operations, and improved drying technologies are
Final Reminder: 1 Week Until SMi’s Lyophilization USA
With the event now just 1 week away, a gentle reminder that there is still time to secure your place at SMi's 3rd annual event, Lyophilization USA, taking place on November 16th and 17th in Iselin, New Jersey. Looking to create a competitive edge, reduce manufacturing costs and shorten cycle time through understanding key parameters in pharmaceutical freeze-drying? Receive guidance on QbD submissions? Gain an overview of the latest innovations
Updates in Cutting Edge Lyophilization Technology
Product temperature is the most important critical quality attribute in a freeze-drying process. During the process, product temperature cannot be controlled directly, but is determined by a combination of process and product parameters. The shelf temperature and chamber pressure are controlled directly based on the user-defined recipe, and constitute the main variables for achieving a suitable product temperature over time profile. Further parameters influence the product temperature as well, such as